Assoc Director, Medical Affairs at Gilead Sciences

Foster City, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceutical, OncologyIndustries

Requirements

Bachelor's degree (minimum; advanced degree implied in context)

Responsibilities

Collaborates with oncology therapeutic area leads in the execution of core Medical tactics, including content development, Medical Regulatory Compliance (MRC) reviews, advisory board planning, stakeholder engagement planning, medical congresses, and data generation efforts
Serves as the Medical Strategy point-of-contact for the Gilead Medical Science Liaison (MSL) team to provide training, interpret insights, and support overall Field Medical strategy
Creates and maintains Gilead Oncology Pipeline materials across tumor types in collaboration with Global Medical Affairs, Clinical Development, Alliance Management, and the broader US Medical Affairs team
Provides clinical and scientific input on Independent Medical Education, Grants and/or Investigator-Sponsored Research/Collaborative Research, and Medical Information response documents for oncology products/pipeline molecules, as needed
Demonstrates strong project management/execution skills to ensure the successful delivery of the Local Strategic Plan (strategy plan) and Medical Plan of Action (tactical plan), amongst other projects as assigned
Leads USMA encore publications strategy and execution for impactful oncology data/evidence in collaboration with Global Publications team
Proactively drives initiatives to completion, anticipating obstacles and difficulties that may arise and resolving them in a positive, collaborative manner
Works collaboratively with Gilead personnel across Medical Affairs, Clinical Development, Commercial, Market Access, Health Economics & Outcomes Research, Real World Evidence, and Global Safety
Attends major and disease-specific congresses to coordinate USMA activities with internal and external stakeholders and represents Gilead Oncology, including the presentation of clinical/scientific information to external audiences
National and international travel, including overnight and weekends as required

Skills

Medical Affairs

Oncology

Medical Strategy

Strategic Planning

Cross-functional Collaboration

Therapeutics Development

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free